Prevalence of Anxiety among Hungarian Subjects with Parkinson’s Disease

Although anxiety is one of the most frequent symptoms of Parkinson’s disease (PD), only a few clinical tools can efficiently and reliably detect its presence. The aim of the present study was to validate the Hungarian patient-rated version of Parkinson Anxiety Scale (PAS). A total of 190 PD patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Márton Kovács, Attila Makkos, Rita Weintraut, Kázmér Karádi, József Janszky, Norbert Kovács
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Behavioural Neurology
Online Access:http://dx.doi.org/10.1155/2017/1470149
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555042434973696
author Márton Kovács
Attila Makkos
Rita Weintraut
Kázmér Karádi
József Janszky
Norbert Kovács
author_facet Márton Kovács
Attila Makkos
Rita Weintraut
Kázmér Karádi
József Janszky
Norbert Kovács
author_sort Márton Kovács
collection DOAJ
description Although anxiety is one of the most frequent symptoms of Parkinson’s disease (PD), only a few clinical tools can efficiently and reliably detect its presence. The aim of the present study was to validate the Hungarian patient-rated version of Parkinson Anxiety Scale (PAS). A total of 190 PD patients were enrolled into the clinimetric validation phase of the study and another 590 participated in the cross-sectional screening phase. The presence of anxiety disorder was diagnosed based on the Diagnostic and Statistical Manual of Mental Disorders criteria. The cutoff value for PAS which best discriminated the presence of anxiety from the absence was 12.5 points (sensitivity of 88.6%, specificity of 79.9). The area under the curve was 0.847 whereas the ROC analysis yielded the statistical significance level (p<0.001). The optimal threshold values for mild (Hoehn and Yahr Stage, HYS 1 and 2), moderate (HYS 3), and severe (HYS 4 and 5) disease stages were 10.5, 12.5, and 13.5 points, respectively. Based on the general threshold anxiety occurred in 35.8% of the patients (persistent anxiety: 29.2%, episodic anxiety: 20.7%, and avoidant anxiety disorder: 16.8%). We demonstrate that the PAS is a valid, highly reliable, and sensitive tool for assessing anxiety.
format Article
id doaj-art-472bec59ff5e43ed8bd85ae22ee438f9
institution Kabale University
issn 0953-4180
1875-8584
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Behavioural Neurology
spelling doaj-art-472bec59ff5e43ed8bd85ae22ee438f92025-02-03T05:49:41ZengWileyBehavioural Neurology0953-41801875-85842017-01-01201710.1155/2017/14701491470149Prevalence of Anxiety among Hungarian Subjects with Parkinson’s DiseaseMárton Kovács0Attila Makkos1Rita Weintraut2Kázmér Karádi3József Janszky4Norbert Kovács5Department of Neurology, University of Pécs, Pécs, HungaryDepartment of Neurology, University of Pécs, Pécs, HungaryDepartment of Neurology, University of Pécs, Pécs, HungaryDepartment of Neurology, University of Pécs, Pécs, HungaryDepartment of Neurology, University of Pécs, Pécs, HungaryDepartment of Neurology, University of Pécs, Pécs, HungaryAlthough anxiety is one of the most frequent symptoms of Parkinson’s disease (PD), only a few clinical tools can efficiently and reliably detect its presence. The aim of the present study was to validate the Hungarian patient-rated version of Parkinson Anxiety Scale (PAS). A total of 190 PD patients were enrolled into the clinimetric validation phase of the study and another 590 participated in the cross-sectional screening phase. The presence of anxiety disorder was diagnosed based on the Diagnostic and Statistical Manual of Mental Disorders criteria. The cutoff value for PAS which best discriminated the presence of anxiety from the absence was 12.5 points (sensitivity of 88.6%, specificity of 79.9). The area under the curve was 0.847 whereas the ROC analysis yielded the statistical significance level (p<0.001). The optimal threshold values for mild (Hoehn and Yahr Stage, HYS 1 and 2), moderate (HYS 3), and severe (HYS 4 and 5) disease stages were 10.5, 12.5, and 13.5 points, respectively. Based on the general threshold anxiety occurred in 35.8% of the patients (persistent anxiety: 29.2%, episodic anxiety: 20.7%, and avoidant anxiety disorder: 16.8%). We demonstrate that the PAS is a valid, highly reliable, and sensitive tool for assessing anxiety.http://dx.doi.org/10.1155/2017/1470149
spellingShingle Márton Kovács
Attila Makkos
Rita Weintraut
Kázmér Karádi
József Janszky
Norbert Kovács
Prevalence of Anxiety among Hungarian Subjects with Parkinson’s Disease
Behavioural Neurology
title Prevalence of Anxiety among Hungarian Subjects with Parkinson’s Disease
title_full Prevalence of Anxiety among Hungarian Subjects with Parkinson’s Disease
title_fullStr Prevalence of Anxiety among Hungarian Subjects with Parkinson’s Disease
title_full_unstemmed Prevalence of Anxiety among Hungarian Subjects with Parkinson’s Disease
title_short Prevalence of Anxiety among Hungarian Subjects with Parkinson’s Disease
title_sort prevalence of anxiety among hungarian subjects with parkinson s disease
url http://dx.doi.org/10.1155/2017/1470149
work_keys_str_mv AT martonkovacs prevalenceofanxietyamonghungariansubjectswithparkinsonsdisease
AT attilamakkos prevalenceofanxietyamonghungariansubjectswithparkinsonsdisease
AT ritaweintraut prevalenceofanxietyamonghungariansubjectswithparkinsonsdisease
AT kazmerkaradi prevalenceofanxietyamonghungariansubjectswithparkinsonsdisease
AT jozsefjanszky prevalenceofanxietyamonghungariansubjectswithparkinsonsdisease
AT norbertkovacs prevalenceofanxietyamonghungariansubjectswithparkinsonsdisease